Valproic acid pathophysiology

It came to the market in 1978, and since then its use has broadened to include the treatment of bipolar and schizoaffective disorders, neuropathic pain, and prophylactic treatment of migraines. VPA is used primarily in the treatment of epilepsy and seizures, but is also used in migraine, bipolar, mood, anxiety, and psychiatric disorders [ 1 ]

2024-03-29
    Flonase nasal spray congestion
  1. absence of or decrease in body movement
  2. VPA is used primarily in the treatment of epilepsy and seizures
  3. The therapeutic range for valproic acid is 50-100 mcg/mL
  4. Background
  5. To help reduce unnecessary
  6. Introduction
  7. Cochrane Database Syst Rev
  8. (See "Approach to the adult with metabolic acidosis"